Akebia Therapeutics Inc. buy HC Wainwright
Start price
27.09.23
/
50%
€1.11
Target price
27.09.24
€3.55
Performance (%)
-11.83%
Price
28.05.24
€0.98
Summary
This prediction is currently active. The price of Akebia Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.83%. This prediction currently runs until 27.09.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Akebia Therapeutics Inc. | -6.262% | -6.262% |
iShares Core DAX® | -0.448% | 2.344% |
iShares Nasdaq 100 | 0.834% | 5.019% |
iShares Nikkei 225® | -0.479% | 0.550% |
iShares S&P 500 | -0.352% | 2.631% |
Comments by HC_Wainwright for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.75 price target on the stock.
Ratings data for AKBA provided by MarketBeat
Stopped prediction by HC_Wainwright for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.82
28.03.24
28.03.24
€5.55
28.03.25
28.03.25
-46.24%
28.05.24
28.05.24
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.92
17.11.23
17.11.23
€4.60
17.11.24
17.11.24
3.71%
28.05.24
28.05.24
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.27
28.08.23
28.08.23
€3.47
28.08.24
28.08.24
-22.80%
28.05.24
28.05.24